PTSD/SUD: Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT01029197
Collaborator
(none)
45
1
2
10
4.5

Study Details

Study Description

Brief Summary

Purpose: To conduct a pilot study of a cognitive-behavioral treatment (CBT) for PTSD and substance abuse among persons with serious mental illness (SMI) treated in a community setting.

Participants: Participants will be 50 volunteer adult individuals with PTSD and substance use disorders (SUD), and SMI who are receiving services at the Freedom House Recovery Center, served through the Orange Person Chatham (OPC) Area Program.

Procedures (methods): Participants will be randomly assigned to one of two conditions: 1) the CBT intervention plus treatment as usual; or, 2) treatment as usual.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CBT and exposure therapy for PTSD
  • Other: Treatment as Usual
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multicomponent Cognitive Behavioral Therapy for Posttraumatic Stress Disorder and Substance Abuse: A Pilot Study
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Jun 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBT Intervention

The CBT intervention includes psychoeducation and coping and social skills delivered in a group format, and exposure therapy delivered in individual sessions

Behavioral: CBT and exposure therapy for PTSD
The CBT intervention will be administered twice weekly in group therapy sessions for 7 weeks, and then twice weekly individual sessions for 4 weeks.

Active Comparator: Treatment as Usual

The TAU Condition will receive usual services at the community clinic, which may include medications, individual or group therapy

Other: Treatment as Usual
Participants in the treatment as usual condition will receive their usual services at the community clinic where they receive mental health and substance abuse services

Outcome Measures

Primary Outcome Measures

  1. Clinician Administered PTSD Scale [3 months]

Secondary Outcome Measures

  1. Addiction Severity Index [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Must be at least 18 years of age

  • Currently receiving services at Freedom House

  • Meet DSM-IV criteria for PTSD

  • Meet criteria for Substance Use Disorder

  • Able to understand and provide informed consent

Exclusion Criteria:

• Psychiatric hospitalization or suicide attempt in the past two months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Freedom House Chapel Hill North Carolina United States 27516

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Karen J Cusack, PhD, University of North Carolina, Chapel Hill
  • Study Director: William Blair, B.S., University of North Carolina, Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01029197
Other Study ID Numbers:
  • 5K01MH079343
First Posted:
Dec 9, 2009
Last Update Posted:
Jul 7, 2010
Last Verified:
Jul 1, 2010

Study Results

No Results Posted as of Jul 7, 2010